Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Russell E. Ware, MD, PhD
Researcher Director of Division of Hematology
Cincinnati Children’s Hospital Medical Center
3333 Burnet Avenue
Cincinnati, Ohio, United States
Russell Ware, MD, PhD, has been involved with a wide variety of clinical and translational hematology research projects for over 25 years, but his primary interests have focused on sickle cell disease. Dr. Ware has substantial personal experience with directing patient-oriented research, and he currently runs an NIH-funded laboratory effort that investigates genetic modifiers of sickle cell disease.
The main focus of his lab research is to understand the phenotypic variability that occurs with hydroxyurea treatment, through the study of hydroxyurea pharmacokinetics, pharmacodynamics, pharmacogenetics, and pharmacogenomics. Dr. Ware is also the national principal investigator for several NIH-funded multicenter sickle cell clinical trials, including the recently completed Stroke With Transfusions Changing to Hydroxyurea (SWiTCH), and the current TCD With Transfusions Changing to Hydroxyurea (TWiTCH) and Sparing Conversion to Abnormal TCD Elevations (SCATE) studies that include non-US clinical sites.
Most recently, Dr. Ware has moved his research efforts into the international arena, starting SCD pilot screening programs in Angola, and now conducting clinical trials to determine the safety and efficacy of hydroxyurea in developing countries.
+myBinderRelated Content
-
University of Illinois HospitalThe Sickle Cell Program at UI Health is ...
-
Foundation For Sickle Cell Disease ResearchThe Foundation for Sickle Cell Disease R...
-
Hassenfeld Children’s Hospital at NYU LangoneHassenfeld Children’s Hospital at NYU ...
-
Olugbenga Olowokure, MDDr. Olugbenga Olowokure is a hematologis...
-
Andrew L. (Larry) Frelinger, PhDDr. Frelinger is Assistant Professor of ...
-
Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease PatientsBackground: High utilization of emergenc...
-
Grant Recipient Uses Mobile Device Observation in Sickle Cell Pain StudyTechnology takes center stage in a new...
